Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasmablast Detection From IgG4-Related Disease Patients

NCT03466970 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT03466970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03466970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasmablast Detection From IgG4-Related Disease Patients
Lead sponsor
Meir Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2018
Completion date
April 1, 2019
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

igg4-related disease